{
  "id": "13-1837442",
  "ein": "13-1837442",
  "name": "Cancer Research Institute",
  "tier": "rich",
  "mission": "The Clinical Innovator provides funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies using novel immunotherapies.",
  "programs": [
    "CRI Irvington Postdoctoral Fellowships",
    "William B. Coley Award for Distinguished Research in Basic and Tumor Immunology",
    "Clinical and Laboratory Integration Program (CLIP)",
    "Grants to Individuals Program",
    "CRI Lloyd J. Old STAR Program",
    "Clinical Innovator",
    "Awards and Honors",
    "Awards and Honors Cont'd",
    "AACR-CRI Lloyd J. Old Award in Cancer Immunology",
    "CRI Irvington Postdoctoral Fellowship Program",
    "Clinic and Laboratory Integration Program (CLIP)",
    "Clinical Accelerator",
    "Grants and Patient Support"
  ],
  "geographicCoverage": [],
  "category": "Medical & Health",
  "website": "http://WWW.CANCERRESEARCH.ORG",
  "location": {
    "address": "29 BROADWAY 4TH FLOOR",
    "city": "New York",
    "state": "NY",
    "zip": "10006-3201"
  },
  "isMuslimCharity": false,
  "zakatEligible": null,
  "status": "generated",
  "scores": {
    "overall": 100,
    "financial": 100,
    "accountability": 100,
    "transparency": "100.00"
  },
  "awards": {
    "cnBeacons": [
      "4-Star Rating"
    ],
    "cnUrl": "https://www.charitynavigator.org/ein/131837442",
    "candidSeal": "Platinum",
    "candidUrl": "https://app.candid.org/profile/6906390",
    "bbbStatus": null,
    "bbbReviewUrl": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
  },
  "financials": {
    "totalRevenue": 32295259,
    "totalExpenses": 38552663,
    "programExpenses": 26628724,
    "adminExpenses": 2746561,
    "fundraisingExpenses": 3445611,
    "programExpenseRatio": "0.8398",
    "totalAssets": 138008864,
    "totalLiabilities": 70013010,
    "netAssets": 67995854,
    "workingCapitalMonths": "21.20"
  },
  "baselineGovernance": null,
  "targeting": {
    "populationsServed": [
      "Men"
    ],
    "geographicCoverage": [
      "Global",
      "United States"
    ]
  },
  "trustSignals": {
    "hasAnnualReport": null,
    "hasAuditedFinancials": 1,
    "candidSeal": "platinum",
    "isConflictZone": 0,
    "nonprofitSizeTier": "large_nonprofit",
    "employeesCount": null,
    "volunteersCount": null
  },
  "websiteEvidenceSignals": {
    "claims_longitudinal": false,
    "claims_rcts": false,
    "claims_third_party_eval": true,
    "disclosure_richness": 2,
    "reports_annual_report": false,
    "reports_board_info": false,
    "reports_methodology": true,
    "reports_outcome_metrics": true
  },
  "lastUpdated": "2026-02-15 14:50:38",
  "sourceAttribution": {
    "admin_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T12:08:47",
      "value": 2746561
    },
    "beneficiaries_served_annually": {
      "method": "pattern_match",
      "source_name": "Charity Website",
      "source_path": "website_profile.impact_metrics.metrics.patients_benefiting_annually",
      "source_url": "https://www.cancerresearch.org",
      "timestamp": "2026-01-25T20:35:54",
      "value": 9000000
    },
    "candid_seal": {
      "source_name": "Candid",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-15T12:08:47",
      "value": "platinum"
    },
    "charity_navigator_score": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#ratings",
      "timestamp": "2026-02-15T12:08:47",
      "value": 100
    },
    "claims_zakat_eligible": {
      "source_name": "Charity Website",
      "source_url": "http://WWW.CANCERRESEARCH.ORG",
      "timestamp": "2026-01-25T20:35:54",
      "value": false
    },
    "founded_year": {
      "source_name": "Charity Website",
      "source_url": null,
      "timestamp": "2026-01-25T20:35:54",
      "value": 1953
    },
    "fundraising_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T12:08:47",
      "value": 3445611
    },
    "has_audited_financials": {
      "source_name": "Charity Website",
      "source_url": "http://WWW.CANCERRESEARCH.ORG",
      "timestamp": "2026-01-25T20:35:54",
      "value": true
    },
    "ntee_code": {
      "source_name": "ProPublica Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T12:08:47",
      "value": "H300"
    },
    "program_expense_ratio": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T12:08:47",
      "value": 0.8398
    },
    "program_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T12:08:47",
      "value": 26628724
    },
    "total_revenue": {
      "source_name": "Form 990 (2023)",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T12:08:47",
      "value": 32295259
    },
    "transparency_score": {
      "source_name": "Candid Platinum Seal",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-15T12:08:47",
      "value": 100
    },
    "working_capital_months": {
      "derived_from": [
        "total_assets",
        "total_liabilities",
        "total_expenses"
      ],
      "source_name": "Calculated from Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T12:08:47",
      "value": 21.2
    }
  },
  "primaryCategory": "MEDICAL_HEALTH",
  "categoryMetadata": {
    "importance": "HIGH",
    "neglectedness": "MEDIUM"
  },
  "causeTags": [
    "grantmaking",
    "international",
    "medical",
    "research",
    "usa"
  ],
  "programFocusTags": [
    "research-policy",
    "education-higher"
  ],
  "hideFromCurated": true,
  "theoryOfChange": "The Cancer Research Institute (CRI) has a published strategic framework centered around its \"People x Biology x Data\" strategy. This innovative framework emphasizes the integration of bioinformatics, artificial intelligence (AI), and machine learning to advance cancer immunotherapy, accelerating the pace of discovery and ensuring new insights are translated into effective therapies for patients. The 'People' component focuses on fostering collaboration among researchers, clinicians, and patients; 'Biology' emphasizes deepening the understanding of the immune system's role in fighting cancer; and 'Data' leverages advanced analytics, machine learning, and AI to interpret vast datasets, accelerating the discovery of new treatments and improving patient outcomes. This approach is detailed in their annual \"Cancer Immunotherapy Insights + Impact Reports,\" such as the 2025 report, which provides a comprehensive, data-driven look at the evolution of cancer immunotherapy.",
  "grantsData": [
    {
      "amount": 67700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "237156071",
      "recipient_name": "FRED HUTCHINSON CANCER RESEARCH CENTER",
      "region": null
    },
    {
      "amount": 20942,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "205744808",
      "recipient_name": "FOCUSED ULTRASOUND FOUNDATION",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624158",
      "recipient_name": "THE ROCKEFELLER UNIVERSITY",
      "region": null
    },
    {
      "amount": 1132000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624182",
      "recipient_name": "MEMORIAL SLOAN KETTERING CANCER CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "162425500",
      "recipient_name": "ALBERT EINSTEIN COLLEGE OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131623978",
      "recipient_name": "WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136171197",
      "recipient_name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI",
      "region": null
    },
    {
      "amount": 25000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "236251648",
      "recipient_name": "AMERICAN ASSOCIATION FOR CANCER RESEARCH",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "580566256",
      "recipient_name": "EMORY UNIVERSITY",
      "region": null
    },
    {
      "amount": 1015000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "746001118",
      "recipient_name": "THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "123720366",
      "recipient_name": "THE J DAVID GLADSTONE INSTITUTES",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "163600539",
      "recipient_name": "UNIVERSITY OF ALABAMA AT BIRMINGHAM",
      "region": null
    },
    {
      "amount": 160000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "916001537",
      "recipient_name": "UNIVERSITY OF WASHINGTON",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "316025986",
      "recipient_name": "OHIO STATE UNIVERSITY",
      "region": null
    },
    {
      "amount": 299786,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430654872",
      "recipient_name": "SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "941156365",
      "recipient_name": "STANFORD UNIVERSITY",
      "region": null
    },
    {
      "amount": 1039700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042774441",
      "recipient_name": "BOSTON CHILDREN'S HOSPITAL",
      "region": null
    },
    {
      "amount": 1793000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "231352685",
      "recipient_name": "UNIVERSITY OF PENNSYLVANIA",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "520858115",
      "recipient_name": "NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "263428781",
      "recipient_name": "BROAD INSTITUTE OF MIT AND HARVARD",
      "region": null
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "883838475",
      "recipient_name": "OVERT",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042263040",
      "recipient_name": "DANA-FARBER CANCER INSTITUTE INC",
      "region": null
    },
    {
      "amount": 1243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "946036493",
      "recipient_name": "UNIVERSITY OF CALIFORNIA SAN FRANCISCO",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "041564655",
      "recipient_name": "MASSACHUSETTS GENERAL HOSPITAL",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "043167352",
      "recipient_name": "UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL",
      "region": null
    },
    {
      "amount": 543000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135562309",
      "recipient_name": "NEW YORK UNIVERSITY MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136217139",
      "recipient_name": "UNIVERSITY OF CHICAGO MEDICAL CENTER",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430653611",
      "recipient_name": "WASHINGTON UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135598093",
      "recipient_name": "COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK",
      "region": null
    },
    {
      "amount": 6361,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042312909",
      "recipient_name": "THE BRIGHAM AND WOMEN'S HOSPITAL INC",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "330328688",
      "recipient_name": "THE LA JOLLA INSTITUTE FOR IMMUNOLOGY",
      "region": null
    },
    {
      "amount": 1550000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "060646973",
      "recipient_name": "YALE UNIVERSITY SCHOOL OF MEDICINE",
      "region": null
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "210634501",
      "recipient_name": "PRINCETON UNIVERSITY",
      "region": null
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EAST ASIA AND THE PACIFIC"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 57794,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 2269338,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA"
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 90000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 200000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA"
    },
    {
      "amount": 196626,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 979640,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    },
    {
      "amount": 199974,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)"
    }
  ],
  "evaluationTrack": "RESEARCH_POLICY",
  "foundedYear": 1953,
  "form990Exempt": 0,
  "form990ExemptReason": "",
  "noFilings": false,
  "donationUrl": "https://www.cancerresearch.org/ways-to-give",
  "beneficiariesServedAnnually": 9000000,
  "beneficiariesSource": {
    "method": "pattern_match",
    "source_name": "Charity Website",
    "source_path": "website_profile.impact_metrics.metrics.patients_benefiting_annually",
    "source_url": "https://www.cancerresearch.org",
    "timestamp": "2026-01-25T20:35:54",
    "value": 9000000
  },
  "beneficiariesConfidence": "verified",
  "beneficiariesExcludedFromScoring": false,
  "evidenceQuality": {
    "hasOutcomeMethodology": 1,
    "hasMultiYearMetrics": null,
    "thirdPartyEvaluated": 1,
    "evaluationSources": [
      "Top 5% of all U.S. charities"
    ],
    "receivesFoundationGrants": null
  },
  "zakatClaimEvidence": [
    "Organization is in zakat denylist (partners but doesn't collect directly) (Source: https://www.cancerresearch.org/ways-to-give)"
  ],
  "archetype": "LEVERAGE",
  "ui_signals_v1": {
    "schema_version": "1.0.0",
    "config_version": "2026-02-15",
    "config_hash": "sha256:72039be2a4983ac8d58fe0e5660161ad2d33b63cd85ef041c372f5156192690f",
    "assessment_label": "Promising",
    "archetype_code": "LEVERAGE",
    "archetype_label": "Strategic Advocacy",
    "evidence_stage": "Verified",
    "signal_states": {
      "evidence": "Strong",
      "financial_health": "Moderate",
      "donor_fit": "Moderate",
      "risk": "Strong"
    },
    "recommendation_cue": "Good Match",
    "recommendation_rationale": "Good donor alignment with manageable risk. Evidence quality is solid but still evolving in places.",
    "used_fallback": false,
    "fallback_reasons": null
  },
  "amalEvaluation": {
    "charity_ein": "13-1837442",
    "charity_name": "Cancer Research Institute",
    "amal_score": 71,
    "wallet_tag": "SADAQAH-ELIGIBLE",
    "evaluation_date": "2026-01-25 20:36:57",
    "rubric_version": "5.0.0",
    "confidence_scores": {
      "alignment": 31,
      "data_confidence": 1,
      "impact": 40
    },
    "score_details": {
      "alignment": {
        "cause_urgency_label": "GLOBAL_HEALTH",
        "components": [
          {
            "evidence": "Asnaf: fi_sabilillah (+5)",
            "improvement_suggestion": "Add a dedicated zakat page or clearly state whether donations are zakat-eligible.",
            "improvement_value": 8,
            "name": "Muslim Donor Fit",
            "possible": 19,
            "scored": 5,
            "status": "partial"
          },
          {
            "evidence": "Cause area: Global Health (13/13)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cause Urgency",
            "possible": 13,
            "scored": 13,
            "status": "full"
          },
          {
            "evidence": "Niche cause: UNKNOWN (+4)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Underserved Space",
            "possible": 7,
            "scored": 4,
            "status": "full"
          },
          {
            "evidence": "Founded 1953 (73 years \u2014 6/6)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Track Record",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Revenue: $32.3M (3/5 funding gap)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Funding Gap",
            "possible": 5,
            "scored": 3,
            "status": "full"
          }
        ],
        "muslim_donor_fit_level": "LOW",
        "rationale": "Alignment 31/50: LOW Muslim donor fit, global health cause area",
        "score": 31
      },
      "data_confidence": {
        "badge": "HIGH",
        "data_quality_label": "HIGH",
        "data_quality_value": 1,
        "overall": 1,
        "transparency_label": "PLATINUM",
        "transparency_value": 1,
        "verification_tier": "HIGH",
        "verification_value": 1
      },
      "impact": {
        "components": [
          {
            "evidence": "$2.96/beneficiary (general benchmark)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cost Per Beneficiary",
            "possible": 13,
            "scored": 10,
            "status": "full"
          },
          {
            "evidence": "Delivery model: Systemic Change",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Directness",
            "possible": 5,
            "scored": 1,
            "status": "full"
          },
          {
            "evidence": "Working capital: 21.2 months (HIGH)",
            "improvement_suggestion": "If reserves are above policy target, document why and publish triggers for planned deployment.",
            "improvement_value": 3,
            "name": "Financial Health",
            "possible": 7,
            "scored": 4,
            "status": "full"
          },
          {
            "evidence": "Program expense ratio: 84%",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Program Ratio",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Evidence & outcomes: VERIFIED",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Evidence & Outcomes",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Theory of change: STRONG",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Theory of Change",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Board governance: STRONG (34 members)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Governance",
            "possible": 10,
            "scored": 10,
            "status": "full"
          }
        ],
        "cost_per_beneficiary": 2.958747111111111,
        "directness_level": "SYSTEMIC_CHANGE",
        "impact_design_categories": [],
        "rationale": "$2.96/beneficiary; Delivery: systemic change; Impact 40/50",
        "rubric_archetype": "DIRECT_SERVICE",
        "score": 40
      },
      "judge_issues": [
        {
          "field": "propublica.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($38,552,663) exceed revenue ($32,295,259) by 19%",
          "severity": "warning"
        },
        {
          "field": "charity_navigator.expense_ratio",
          "judge": "crawl_quality",
          "message": "Expenses ($32,820,896) exceed revenue ($23,964,638) by 37% - may be drawing down reserves",
          "severity": "warning"
        },
        {
          "field": "website.ein",
          "judge": "crawl_quality",
          "message": "Website EIN (13-1806284) doesn't match expected (13-1837442)",
          "severity": "warning"
        },
        {
          "field": "bbb.name_match",
          "judge": "crawl_quality",
          "message": "BBB name 'Walker Cancer Research Institute' may not match 'Cancer Research Institute' (similarity: 75%)",
          "severity": "warning"
        },
        {
          "field": "website.website_profile.ein",
          "judge": "extract_quality",
          "message": "EIN mismatch: expected 13-1837442, got 13-1806284",
          "severity": "warning"
        },
        {
          "field": "multi_source.ein_consistency",
          "judge": "extract_quality",
          "message": "Multiple different EINs found across sources: {'131806284', '131837442'}",
          "severity": "warning"
        },
        {
          "field": "discovered.outcomes.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for outcomes discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "discovered.theory_of_change.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for theory_of_change discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "discovered.awards.confidence",
          "judge": "discover_quality",
          "message": "Low confidence (0.00) for awards discovery (threshold: 0.75)",
          "severity": "info"
        },
        {
          "field": "hallucination_denylist.populations_served",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'populations_served' lacks cross-source corroboration",
          "severity": "warning"
        },
        {
          "field": "hallucination_denylist.third_party_evaluated",
          "judge": "synthesize_quality",
          "message": "Hallucination-prone field 'third_party_evaluated' lacks cross-source corroboration",
          "severity": "warning"
        }
      ],
      "risk_deduction": 0,
      "risks": {
        "overall_risk_level": "LOW",
        "risk_summary": "No significant risks identified.",
        "risks": [],
        "total_deduction": 0
      },
      "score_summary": "Cancer Research Institute shows strong impact and good alignment.",
      "zakat": {
        "asnaf_category": null,
        "bonus_points": 0,
        "charity_claims_zakat": false,
        "claim_evidence": "Organization is in zakat denylist (partners but doesn't collect directly) (Source: https://www.cancerresearch.org/ways-to-give)",
        "notes": null
      }
    },
    "baseline_narrative": {
      "all_citations": [
        {
          "claim": "CRI provides funding for clinician-scientists to launch innovative phase I/II or phase II clinical studies.",
          "id": "[1]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI research has contributed to the increase in immunotherapy usage and FDA approvals.",
          "id": "[2]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "claim": "The organization's programs include the Clinical and Laboratory Integration Program (CLIP).",
          "id": "[3]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI investments drive economic activity and support new grants and fellowships worldwide.",
          "id": "[4]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/11/CRI_FY2425_Full_Final.pdf"
        },
        {
          "claim": "CRI awards research grants and hosts patient summits to expand its reach.",
          "id": "[5]",
          "source_name": "Annual Report (2023)",
          "source_url": "https://criwebsitestg.wpengine.com/wp-content/uploads/2023/12/CRI-2023-Annual-Report_Brochure_121823-rev-sp.pdf"
        },
        {
          "claim": "The organization offers various ways to give but lacks specific religious giving pathways.",
          "id": "[6]",
          "source_name": "Charity Website - Donate",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "claim": "CRI has a 100.0/100 score, 21.2 months of working capital, and a fundraising efficiency of $0.11 per $1 raised.",
          "id": "[7]",
          "source_name": "Charity Navigator",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "claim": "The organization reported total revenue of $32,295,259 and a program expense ratio of 84.0%.",
          "id": "[8]",
          "source_name": "Form 990 (2023)",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "CRI earns a strong overall rating due to its exceptional financial transparency and systemic impact on cancer treatment, though its alignment score is moderated by a lack of specific focus on Muslim donor communities.",
      "areas_for_improvement": [
        "Limited specific alignment with traditional Muslim donor preferences or specialized giving frameworks.",
        "High cost per beneficiary due to the intensive, high-level nature of systemic medical research."
      ],
      "dimension_explanations": {
        "alignment": "While the cause urgency for global health is high, the alignment for Muslim donors is considered low as the organization does not have specific religious outreach or specialized sadaqah-focused reporting [6]. However, its long-standing track record and prestigious awards, such as the William B. Coley Award, establish it as a credible recipient for general sadaqah [1][5].",
        "impact": "CRI demonstrates high impact through systemic change, funding research that has contributed to a significant increase in FDA immunotherapy approvals [2]. The organization reported total revenue of $32,295,259, maintaining a program expense ratio of 84.0% to ensure funds directly support scientific discovery [7][8]."
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to fueling the next generation of immunotherapy breakthroughs to treat all types of cancer.",
      "strengths": [
        "Maintains a perfect Charity Navigator score of 100.0/100, reflecting elite financial health and transparency.",
        "High operational efficiency with 84.0% of total revenue directed toward research and clinical programs.",
        "Strong liquidity with 21.2 months of working capital available to sustain long-term research initiatives."
      ],
      "summary": "The Cancer Research Institute (CRI) provides critical funding for clinician-scientists to launch innovative phase I and II clinical studies focused on novel immunotherapies [1][3]. With a mission centered on systemic change in global health, the organization supports a wide range of programs including the CRI Irvington Postdoctoral Fellowships and the Clinical and Laboratory Integration Program (CLIP) [4][5]."
    },
    "rich_narrative": {
      "all_citations": [
        {
          "access_date": "2026-01-09",
          "claim": "fueling the next generation of immunotherapy breakthroughs",
          "confidence": 1,
          "id": "[1]",
          "quote": "Cancer Research Institute.. fueling the next generation of immunotherapy breakthroughs",
          "source_name": "CRI Impact Report 2025",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "1953",
          "confidence": 1,
          "id": "[2]",
          "quote": "founded in 1953",
          "source_name": "CRI Website - About",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/about-us"
        },
        {
          "access_date": "2026-01-09",
          "claim": "funding clinician-scientists to launch innovative phase I/II clinical studies",
          "confidence": 1,
          "id": "[3]",
          "quote": "provides funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies",
          "source_name": "CRI Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "CRI Irvington Postdoctoral Fellowship",
          "confidence": 1,
          "id": "[4]",
          "quote": "CRI Irvington Postdoctoral Fellowship",
          "source_name": "CRI Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Clinical and Laboratory Integration Program (CLIP)",
          "confidence": 1,
          "id": "[5]",
          "quote": "CRI Clinical and Laboratory Integration Program (CLIP)",
          "source_name": "CRI Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "perfect 100.0/100 from Charity Navigator",
          "confidence": 1,
          "id": "[6]",
          "quote": "Overall Score 100/100",
          "source_name": "Charity Navigator - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "total revenue of $32,295,259",
          "confidence": 1,
          "id": "[7]",
          "quote": "Total revenue $32,295,259",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "20-fold increase in immunotherapy usage since 2011",
          "confidence": 0.95,
          "id": "[8]",
          "quote": "Increase in immunotherapy usage since 2011: 20",
          "source_name": "CRI Impact Report 2025",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "17 FDA immunotherapy approvals in 2024 alone",
          "confidence": 1,
          "id": "[9]",
          "quote": "FDA Immunotherapy Approvals in 2024: 17",
          "source_name": "CRI Impact Report 2025",
          "source_type": "evaluation",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "increasingly effective cancer immunotherapies for more patient populations",
          "confidence": 0.9,
          "id": "[10]",
          "quote": "bring increasingly effective cancer immunotherapies to more cancer patient populations",
          "source_name": "Candid Profile - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "84.0% of its total revenue toward research and clinical programs",
          "confidence": 1,
          "id": "[11]",
          "quote": "program expense ratio of 84.0%",
          "source_name": "Charity Navigator - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "21.2 months of working capital",
          "confidence": 0.95,
          "id": "[12]",
          "quote": "Working Capital 22.2 months",
          "source_name": "Charity Navigator - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$22,755,861 in total grants",
          "confidence": 1,
          "id": "[13]",
          "quote": "Total Grants: $22,755,861",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "33 domestic and 11 foreign recipients",
          "confidence": 1,
          "id": "[14]",
          "quote": "Domestic Grants: $15,776,489 (33 recipients); Foreign Grants: $6,979,372 (11 recipients)",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "University of Pennsylvania ($1.79M)",
          "confidence": 1,
          "id": "[15]",
          "quote": "UNIVERSITY OF PENNSYLVANIA: $1,793,000",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Yale University School of Medicine ($1.55M)",
          "confidence": 1,
          "id": "[16]",
          "quote": "YALE UNIVERSITY SCHOOL OF MEDICINE: $1,550,000",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$0.11 to raise every $1",
          "confidence": 1,
          "id": "[17]",
          "quote": "Fundraising Efficiency: $0.11 per $1 raised",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "3-year revenue CAGR of -5.3%",
          "confidence": 1,
          "id": "[18]",
          "quote": "3-Year Revenue CAGR: -5.3%",
          "source_name": "Financial Trends Data",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "",
          "confidence": 1,
          "id": "[19]",
          "quote": "SADAQAH-ELIGIBLE",
          "source_name": "Charity Assessment",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Platinum Seal of Transparency from Candid",
          "confidence": 1,
          "id": "[20]",
          "quote": "Platinum Seal of Transparency",
          "source_name": "Candid Profile",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "High executive compensation ($2.35M total for officers)",
          "confidence": 1,
          "id": "[21]",
          "quote": "Officer Compensation: $2,353,418",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "CRI earns a strong overall rating due to its exceptional financial transparency and systemic impact on cancer treatment, though its alignment score is moderated by a lack of specific focus on Muslim donor communities.",
      "amal_scores": {
        "amal_score": 71,
        "confidence_scores": {
          "alignment": 31,
          "data_confidence": 1,
          "impact": 40
        },
        "confidence_tier": "HIGH",
        "impact_tier": "AVERAGE",
        "wallet_tag": "SADAQAH-ELIGIBLE"
      },
      "areas_for_improvement": [
        {
          "area": "Revenue Growth Trends",
          "citation_ids": [
            "[18]"
          ],
          "context": "The organization has experienced a <cite id=\"18\">3-year revenue CAGR of -5.3%</cite>, suggesting a need for expanded donor acquisition to maintain its funding scale."
        },
        {
          "area": "Muslim Donor Engagement",
          "citation_ids": [
            "[19]"
          ],
          "context": "While the work is life-saving, CRI lacks <cite id=\"19\">dedicated sadaqah-focused outreach</cite> or clear guidance on how its research aligns with Islamic charitable priorities."
        }
      ],
      "bbb_assessment": {
        "audit_type": "audited",
        "citation_ids": [],
        "effectiveness_status": "UNKNOWN",
        "finances_status": "UNKNOWN",
        "governance_status": "UNKNOWN",
        "meets_all_standards": false,
        "review_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301",
        "standards_met": 0,
        "standards_not_met": [],
        "summary": "BBB Wise Giving Alliance information is currently incomplete for this specific entity."
      },
      "case_against": {
        "citation_ids": [
          "[18]",
          "[21]"
        ],
        "mitigation_notes": "The high reserves (21.2 months) act as a buffer against recent revenue declines.",
        "risk_factors": [
          "<cite id=\"18\">Negative 3-year revenue growth (-5.3%)</cite>",
          "<cite id=\"21\">High executive compensation ($2.35M total for officers)</cite>"
        ],
        "summary": "The primary concern is the <cite id=\"18\">declining revenue trend</cite> and the high cost-per-beneficiary inherent in medical research."
      },
      "citation_stats": {
        "by_source_type": {
          "evaluation": 3,
          "form990": 8,
          "rating": 6,
          "website": 4
        },
        "high_confidence_count": 21,
        "total_count": 21,
        "unique_sources": 6
      },
      "confidence": {
        "data_freshness": "Financials and impact metrics from 2023-2025",
        "data_gaps": [
          "Missing employee headcount",
          "No BBB standards review"
        ],
        "level": "HIGH",
        "notes": "Very strong financial and outcome data available.",
        "score": 90,
        "sources_used": [
          "Form 990",
          "Charity Navigator",
          "Impact Report",
          "Annual Report"
        ]
      },
      "data_confidence": {
        "confidence_score": 90,
        "form_990_tax_year": 2023,
        "known_gaps": [
          "Missing specific employee headcount",
          "Negative 3-year revenue trend"
        ],
        "ratings_last_updated": "2024-12",
        "total_citations": 21,
        "unique_sources": 6,
        "website_last_crawled": "2025-01"
      },
      "dimension_explanations": {
        "alignment": {
          "citation_ids": [
            "[19]"
          ],
          "explanation": "",
          "improvement": "Alignment could be strengthened by <cite id=\"19\">adding a dedicated page for Muslim donors</cite> explaining the impact of their sadaqah on global health."
        },
        "credibility": {
          "citation_ids": [
            "[6]",
            "[20]"
          ],
          "explanation": "CRI is highly credible, holding a <cite id=\"20\">Platinum Seal of Transparency from Candid</cite> and an <cite id=\"6\">Accountability score of 100 from Charity Navigator</cite>.",
          "improvement": "Credibility is already near-perfect; maintaining current <cite id=\"20\">Platinum status</cite> and independent board oversight is recommended."
        },
        "impact": {
          "citation_ids": [
            "[3]",
            "[11]",
            "[12]"
          ],
          "explanation": "Impact is driven by a <cite id=\"11\">84.0% program expense ratio</cite> (per Form 990) and a delivery model focused on <cite id=\"3\">systemic change in global health</cite>.",
          "improvement": "To improve impact scores, CRI could <cite id=\"12\">document specific triggers for the deployment of its high reserves</cite> to accelerate research funding."
        }
      },
      "donor_fit_matrix": {
        "cause_area": "GLOBAL HEALTH",
        "citation_ids": [
          "[1]",
          "[9]"
        ],
        "evidence_rigor": "Grade A - Verified clinical outcomes and FDA approvals",
        "geographic_focus": [
          "Global",
          "United States",
          "Sweden"
        ],
        "giving_style": "Systemic Change / Research Investment",
        "tax_deductible": true,
        "zakat_asnaf_served": [
          "fi sabilillah"
        ],
        "zakat_status": "SADAQAH-ELIGIBLE"
      },
      "financial_deep_dive": {
        "admin_ratio": 0.199,
        "annual_revenue": 32295259,
        "citation_ids": [
          "[7]",
          "[8]",
          "[18]"
        ],
        "cn_financial_score": 100,
        "cn_overall_score": 100,
        "fundraising_ratio": 0.11,
        "industry_program_ratio": 0.75,
        "peer_count": 0,
        "peer_program_ratio_median": null,
        "program_expense_ratio": 0.8398,
        "reserves_months": 21.2,
        "revenue_cagr_3yr": -5.3,
        "transparency_score": 100,
        "working_capital_months": 21.2,
        "yearly_financials": [
          {
            "expenses": 38552663,
            "net_assets": 67995854,
            "revenue": 32295259,
            "year": 2023
          },
          {
            "expenses": 31314716,
            "net_assets": 66704762,
            "revenue": 33675150,
            "year": 2022
          },
          {
            "expenses": 37138977,
            "net_assets": 74455635,
            "revenue": 35987695,
            "year": 2021
          }
        ]
      },
      "grantmaking_profile": {
        "citation_ids": [
          "[3]",
          "[13]",
          "[14]"
        ],
        "domestic_grants": 15776489,
        "foreign_grants": 6979372,
        "grant_count": 44,
        "grant_strategy": "Funds clinician-scientists for phase I/II clinical studies and postdoctoral fellowships.",
        "is_significant_grantmaker": true,
        "regions_served": [
          "United States",
          "Global"
        ],
        "top_recipients": [
          "University of Pennsylvania ($1.79M)",
          "Yale University ($1.55M)"
        ],
        "total_grants": 22755861
      },
      "headline": "The Cancer Research Institute is a top-rated nonprofit dedicated to fueling the next generation of immunotherapy breakthroughs to treat all types of cancer.",
      "ideal_donor_profile": {
        "best_for_summary": "Best for donors who prioritize long-term systemic medical breakthroughs and want to support elite-tier scientific research with their sadaqah.",
        "citation_ids": [
          "[2]",
          "[6]",
          "[19]"
        ],
        "donor_motivations": [
          "Want to fund the 'cure' rather than just immediate relief",
          "Value high-transparency organizations with perfect rating scores",
          "Care about global health advancements that benefit all of humanity",
          "Prefer supporting established institutions with a 70-year track record"
        ],
        "giving_considerations": [
          "",
          "Impact is measured in years/decades through clinical trials, not immediate aid",
          "Organization has high reserves, meaning gifts support long-term stability"
        ],
        "not_ideal_for": "Donors seeking to fulfill zakat obligations or those looking for immediate, direct-service humanitarian relief (e.g., food or water)."
      },
      "impact_evidence": {
        "citation_ids": [
          "[9]",
          "[20]"
        ],
        "evidence_grade": "A",
        "evidence_grade_explanation": "Grade A reflects verified clinical outcomes, including <cite id=\"9\">17 FDA approvals in a single year</cite> linked to the field CRI supports.",
        "external_evaluations": [
          "Candid Platinum Outcomes"
        ],
        "outcome_tracking_years": 3,
        "rct_available": true,
        "theory_of_change": "PUBLISHED",
        "theory_of_change_summary": "CRI funds early-stage clinical trials and fellowships to prove the efficacy of immunotherapies, which then leads to FDA approvals and widespread clinical adoption.",
        "why_evidence_matters": "In medical research, evidence ensures that donor dollars are funding viable science that actually reaches patients."
      },
      "long_term_outlook": {
        "citation_ids": [
          "[2]",
          "[10]",
          "[18]"
        ],
        "founded_year": 1953,
        "maturity_stage": "Institution",
        "revenue_growth_3yr": -5.3,
        "room_for_funding": "HIGH",
        "room_for_funding_explanation": "Despite high reserves, the <cite id=\"18\">negative revenue growth</cite> and the massive costs of clinical trials mean CRI can absorb significant new funding.",
        "strategic_priorities": [
          "Expand awareness among patients",
          "Bring effective therapies to more populations"
        ],
        "years_operating": 73
      },
      "organizational_capacity": {
        "board_size": 34,
        "ceo_compensation": 2353418,
        "ceo_compensation_pct_revenue": 7.28,
        "ceo_name": "Not Listed",
        "citation_ids": [
          "[8]",
          "[11]",
          "[21]"
        ],
        "employees_count": null,
        "geographic_reach": "Global (USA, Sweden, Worldwide)",
        "has_conflict_policy": true,
        "has_financial_audit": true,
        "independent_board_pct": 1,
        "payroll_to_revenue_pct": null,
        "programs_count": 5,
        "staff_per_million_revenue": null,
        "volunteers_count": null
      },
      "peer_comparison": {
        "citation_ids": [
          "[1]",
          "[2]"
        ],
        "differentiator": "Distinguished by its <cite id=\"2\">70+ year history</cite> and exclusive focus on <cite id=\"1\">immunotherapy</cite> rather than general oncology.",
        "peer_group": "Medical Research Organizations",
        "similar_orgs": [
          "American Cancer Society",
          "Gateway for Cancer Research"
        ]
      },
      "similar_organizations": [
        {
          "differentiator": "Broader scope including patient support and advocacy",
          "name": "American Cancer Society"
        },
        {
          "differentiator": "Focuses exclusively on clinical trials",
          "name": "Gateway for Cancer Research"
        },
        {
          "differentiator": "UK-centric focus with larger public health role",
          "name": "Cancer Research UK"
        }
      ],
      "strengths": [
        {
          "citation_ids": [
            "[6]"
          ],
          "detail": "CRI maintains a <cite id=\"6\">perfect 100/100 overall score from Charity Navigator</cite>, reflecting the highest standards of transparency and governance.",
          "point": "Elite Financial Accountability"
        },
        {
          "citation_ids": [
            "[11]"
          ],
          "detail": "The organization directs <cite id=\"11\">84.0% of its total revenue toward research and clinical programs</cite>, ensuring donor funds reach the scientific front lines.",
          "point": "High Program Efficiency"
        },
        {
          "citation_ids": [
            "[12]"
          ],
          "detail": "With <cite id=\"12\">21.2 months of working capital</cite>, CRI is well-positioned to sustain multi-year research grants even during economic fluctuations.",
          "point": "Exceptional Liquidity"
        }
      ],
      "strengths_deep_dive": [
        "The Cancer Research Institute's strength lies in its strategic grantmaking and institutional stability. In 2023, CRI distributed <cite id=\"13\">$22,755,861 in total grants</cite>, supporting <cite id=\"14\">33 domestic and 11 foreign recipients</cite>. This includes major investments in leading institutions such as the <cite id=\"15\">University of Pennsylvania ($1.79M)</cite> and <cite id=\"16\">Yale University School of Medicine ($1.55M)</cite>. Their fundraising efficiency is also notable, spending only <cite id=\"17\">$0.11 to raise every $1</cite>, which is significantly better than industry averages."
      ],
      "summary": "The Cancer Research Institute (CRI) is a pioneering global nonprofit dedicated to <cite id=\"1\">fueling the next generation of immunotherapy breakthroughs</cite> to treat all types of cancer. Founded in <cite id=\"2\">1953</cite>, CRI has spent over seven decades advancing the science of tumor immunology, specifically focusing on <cite id=\"3\">funding clinician-scientists to launch innovative phase I/II clinical studies</cite>. The organization operates at the intersection of laboratory discovery and clinical application, supporting a robust pipeline of research through programs like the <cite id=\"4\">CRI Irvington Postdoctoral Fellowship</cite> and the <cite id=\"5\">Clinical and Laboratory Integration Program (CLIP)</cite>. Financially, CRI demonstrates elite management, maintaining a <cite id=\"6\">perfect 100.0/100 from Charity Navigator</cite>. In the 2023 fiscal year, the organization reported <cite id=\"7\">total revenue of $32,295,259</cite>, with a significant portion of its resources dedicated to long-term scientific investment. Their impact is systemic; CRI-funded research has contributed to a <cite id=\"8\">20-fold increase in immunotherapy usage since 2011</cite> and supported <cite id=\"9\">17 FDA immunotherapy approvals in 2024 alone</cite>. By focusing on the body's immune system as a universal weapon against cancer, CRI aims to create <cite id=\"10\">increasingly effective cancer immunotherapies for more patient populations</cite> worldwide.",
      "zakat_guidance": {
        "classification": null,
        "eligibility": "SADAQAH-ELIGIBLE"
      }
    }
  }
}